{
  "docId": "019de071-be30-70fc-a858-8f20c51da6b3",
  "docSlug": "a62013e96cbc38ce4e129c5b57bb4496",
  "documentTitle": "Chimerix | Investor Conference Presentation Deck | 32 slides",
  "authorId": "chimerix",
  "authorName": "Chimerix",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 32,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "other",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a biological pathway diagram to explain the drug's mechanism of action.",
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de071-be30-70fc-a858-8f20c51da6b3/5",
  "deckHref": "/decks/019de071-be30-70fc-a858-8f20c51da6b3",
  "deckJsonHref": "/decks/019de071-be30-70fc-a858-8f20c51da6b3.json",
  "deckAnchorHref": "/decks/019de071-be30-70fc-a858-8f20c51da6b3#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.48,
        "x": 0.07,
        "y": 0.215
      },
      "kind": "image",
      "text": "Mechanism of action diagram showing ClpP and DRD2 interaction",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "366ce533-b438-4ffe-ba52-00430847457b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.38,
        "x": 0.58,
        "y": 0.18
      },
      "kind": "list",
      "text": "Oral small molecule\nOnce weekly dosing based on pharmacodynamics\nWell tolerated\nDRD2 antagonist and ClpP agonist that induces tumor cell apoptosis",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a74a675b-8c1b-49c5-84ac-63b2821c474b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.15,
        "y": 0.8
      },
      "kind": "source-note",
      "text": "Allen et al., Science Translational Medicine, 2013; Ishizawa et al, Science Signaling, 2016; Kline et al, Science Signaling, 2016; Siegelin et al, Clinical Cancer Research, 2018; Ishizawa et al, Cancer Cell, 2019",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "666bd911-a480-4906-8c89-34c22698d4c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.5,
        "x": 0.04,
        "y": 0.03
      },
      "kind": "title",
      "text": "ONC201 Is a DRD2 Antagonist/ClpP Agonist",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11efd392-2449-4a50-964c-f205b22df601",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 4,
      "beatId": "4cf972a8-ed9f-487c-bfdd-b107cef09f22",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The presentation identifies the problem of diffuse midline glioma, H3 K27M-mutant",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}